This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Matthew B. Soellner
Introduction
Matthew B. Soellner is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of inhibitors for specific receptor pathways. His work is crucial for advancing treatments for various disorders.
Latest Patents
Matthew holds a patent for "Substituted pyrimidines and methods of use." This patent provides inhibitors of activin receptor-like kinase 5 (ALK5). The disclosure includes methods to modulate the activity of ALK5 and outlines treatment methods for disorders mediated by this receptor. He has 1 patent to his name.
Career Highlights
Matthew is currently employed at Theravance Biopharma R&D IP, LLC, where he continues to innovate in the biopharmaceutical sector. His research focuses on developing new therapeutic strategies that target specific biological pathways.
Collaborations
Matthew has collaborated with talented professionals such as Mandy Loo and Svitlana Kulyk. Their combined expertise enhances the research and development efforts at Theravance Biopharma.
Conclusion
Matthew B. Soellner's contributions to the field of biopharmaceuticals exemplify the impact of innovative research on medical treatments. His work continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile